To Compare the Efficacy and Safety of Tripterygium Wilfordii (TW) Versus Valsartan in the Membranous Nephropathy (MN)

Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet

NCT00518765 ·Status: COMPLETED ·Phase: PHASE3

Effect of Valsartan on Proteinuria in Patients With Hypertension and Diabetes Mellitus

NCT00241085 ·Status: COMPLETED ·Phase: PHASE4

Antialbuminuric Effects of Valsartan and Lisinopril

NCT00171600 ·Status: TERMINATED ·Phase: PHASE4

Hypertension and Cardiovascular Risk Factors

NCT00171782 ·Status: COMPLETED ·Phase: PHASE4

Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy

NCT06501651 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular Disease

NCT00190580 ·Status: COMPLETED ·Phase: PHASE4

A Study in Patients With Diabetes Mellitus Type II of the Effect on Albuminuria of 24 Week Treatment With Valsartan, Benazepril, and Valsartan+Benazepril

NCT00171119 ·Status: TERMINATED ·Phase: PHASE4

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

NCT00413049 ·Status: COMPLETED ·Phase: PHASE3

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

NCT01541189 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe Hypertension

NCT00171535 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

NCT00351130 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Efficacy and Safety of SPH3127 In Patients With Mild-moderate Essential Hypertension

NCT05359068 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

NCT00591578 ·Status: COMPLETED ·Phase: PHASE3

A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by Monotherapy

NCT01241487 ·Status: COMPLETED ·Phase: PHASE4

VALID: Study to Compare the Reduction of Predialysis Systolic Blood Pressure With Valsartan Compared to Irbesartan in Patients With Mild to Moderate Hypertension on Long-term Hemodialysis

NCT00171080 ·Status: COMPLETED ·Phase: PHASE3

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

NCT00241137 ·Status: COMPLETED ·Phase: PHASE3

Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone

NCT00170989 ·Status: COMPLETED ·Phase: PHASE3

Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.

NCT00171561 ·Status: COMPLETED ·Phase: PHASE4

Antiproteinuric Effect of Valsartan and Lisinopril

NCT00171574 ·Status: COMPLETED ·Phase: PHASE4

A Study Of Valsartan Used To Treat Hypertension For Up To 56 Weeks In Children Ages 1 - 5 Years Who Have Hypertension

NCT00171028 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Valsartan and the Combination of Valsartan and Simvastatin

NCT00385931 ·Status: COMPLETED ·Phase: PHASE3

Comparison of Two Treatment Strategies in Hypertensive Patients

NCT00171444 ·Status: COMPLETED ·Phase: PHASE4

Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension

NCT02480764 ·Status: COMPLETED ·Phase: PHASE3

Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension

NCT06395194 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With Hypertension

NCT00171054 ·Status: COMPLETED ·Phase: PHASE4